BNIGF fundamentals
Key facts
Beroni Group Ltd. engages in the development, production, and marketing of biotechnology products. Its products include NicoBloc, Fogibloc, Multi Vigorous tablets and Multi lung cleaning tablets. The company has two business divisions: an innovation pathway consisting of research studies into anti-cancer drugs, cell therapies and detection and treatment of infectious disease, and an e-commerce platform focused on sales of a diverse range of pharmaceutical and healthcare products. The firm was founded by Bo Qing Zhang and Hai Huang on June 17, 2016 and is headquartered in Sydney, Australia.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company